The Singapore location is another step in Cryoport’s strategy to strengthen its footprint in the Asia Pacific (APAC) region to meet the increasing demand by the life sciences industry for its temperature-controlled supply chain solutions. This follows the launch of Cryoport Systems’ and CRYOPDP’s first jointly operated Global Logistics Center in Osaka, Japan in the fourth quarter of 2020.

Located in the heart of the European Union, F-airGate has over two decades of experience in supply chain logistics, with a broad offering that includes premium transport services such as Next Flight Out solutions and Time Critical Courier Solutions. Acquiring F-airGate will expand Cryoport’s presence in the EMEA region (Europe, Middle East and Africa) and is highly synergistic with CRYOPDP’s strong European footprint in the United Kingdom, France, Portugal, Poland, Germany and the Netherlands.

We are excited to announce that CRYOPDP is expanding its global supply chain network and premium services through the acquisition of a market leader in providing healthcare logistics management services in Australia - The company name is: Critical Transport Solutions Australia. 

This new acquisition, which will be operated by CRYOPDP, further expands the Company’s footprint in the Asia-Pacific region and provides immediate key added value to the customers and partners. 

CRYOPDP, the first choice premium courier for Life Sciences and Healthcare industries with more than 25 years of experience, was announced as the winner of the “Best Clinical Trial Logistics Provider” at the annual Asia-Pacific Bioprocessing Excellence Awards 2021.